He. Resnick et al., Apo E genotype, diabetes, and peripheral arterial disease in older men: The Honolulu Asia-Aging study, GENET EPID, 19(1), 2000, pp. 52-63
The epsilon 4 allele of the gene coding for apolipoprotein (apo) E is assoc
iated with an atherogenic lipid profile that has been linked to increased r
isk of coronary artery disease (CAD). Apo E genotype may also be associated
with peripheral arterial disease (PAD). If present, this association may b
e modified by diabetes, which is also associated with dyslipidemia that pre
disposes to macrovascular disease. Observable associations between both Apo
E genotype and diabetes with PAD may be confounded by smoking, a potent PAD
risk factor that is unrelated to lipids. From 1991 to 1993, apo E genotype
s (2/3, 3/3, 3/4), PAD (defined as ankle-brachial index [ABI] <0.9), diabet
es (prevalent and newly-diagnosed), and smoking history (ever/never) were d
etermined for 3,161 Japanese-American men aged 71-93. Data on hypertension
and other potential confounders were also collected. Logistic regression wa
s used to determine odds ratios (OR) between groups cross-categorized by ap
o E genotype and diabetes with prevalence of PAD, within strata of smoking.
In each smoking stratum, non-diabetic apo epsilon 3/3 carriers were consid
ered the reference. Among ever-smokers, there was no association between ap
o E acid PAD, regardless of diabetes status. Among never-smokers there appe
ared to be both apo E- and diabetes effects on PAD prevalence. Compared to
the non-diabetic epsilon 3/3 group, the ORs of PAD were 2.3 (1.2-4.4) and 2
.0 (1.1-3.4) for epsilon 3/3 newly-diagnosed and epsilon 3/3 prevalent diab
etic subjects, respectively. Associations were stronger among diabetic indi
viduals in the epsilon 3/4 group: the ORs were 3.0 (1.1-8.8) and 4.1 (1.9-8
.7) for epsilon 3/4 newly-diagnosed and epsilon 3/4prevalent diabetic subje
cts, respectively. Despite associations whose pattern and magnitude suggest
ed interaction between apo E genotype and diabetes on PAD prevalence among
never-smokers, formal testing of this interaction did not reach statistical
significance. Our finding of an apo E-PAD association among never-smokers
may result from the effects of an apo epsilon 4-related atherogenic lipid p
rofile on peripheral arteries. Further studies are needed to clarify the po
tential mediating role of diabetes on the apo E-PAD association. Genet. Epi
demiol. 19:52-63, 2000. (C) 2000 Wiley-Liss, Inc.